Table 5 Subgroup analysis of the association between sASGR1 and WBC count
Variables | Effect size (95% CI) | P value | P for interaction |
|---|---|---|---|
Age | |||
Below 60 | -0.0 (-0.1, 0.1) | 0.794 | < 0.001 |
Over 60 | 0.3 (0.2, 0.5) | < 0.001 | |
Sex | |||
Male | 0.1 (-0.0, 0.2) | 0.108 | 0.425 |
Female | 0.2 (0.0, 0.3) | 0.038 | |
BMI | |||
<24 | 0.2 (0.0, 0.3) | 0017 | 0.373 |
>=24 | 0.1 (-0.1, 0.2) | 0.311 | |
Statin use | |||
No | 0.1 (0.0, 0.3) | 0.045 | 0.791 |
Yes | 0.1 (-0.0, 0.2) | 0.167 | |
CAD | |||
No | 0.2 (-0.2, 0.5) | 0.326 | 0.771 |
Yes | 0.1 (0.0, 0.2) | 0.029 | |
Hypertension | |||
No | 0.1 (-0.1, 0.2) | 0.314 | 0.089 |
Yes | 0.2 (0.1, 0.3) | 0.006 | |
T2DM | |||
No | 0.1 (0.0, 0.3) | 0.008 | 0.159 |
Yes | 0.0 (-0.2, 0.2) | 0.902 |